Longboard Pharmaceuticals

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel transformative drugs for neurological disorders, initially concentrating on rare diseases. Longboard Pharmaceuticals aims to develop a range of centrally acting drug candidates with high selectivity for specific G protein-coupled receptors (GPCRs).